Polyfunctional antibody signature defines protection in Andes hantavirus survival - Report - MDSpire

Polyfunctional antibody signature defines protection in Andes hantavirus survival

  • By

  • Felipe Bravo

  • Tybbysay P. Salinas

  • Camila Kossack

  • Jorge T. Gonzalez

  • Israel Giacaman

  • Claudio Quevedo

  • Sebastián Fuller

  • Farides Saavedra

  • Claudio Aguilera-Pérez

  • Felipe Aguilera

  • Raúl Riquelme

  • María Luisa Rioseco

  • Mario Calvo

  • Raymond A. Alvarez

  • Juan Miguel Pascale

  • Blas Armién

  • Maritza Navarrete

  • Jose Luis Garrido

  • Maria Ines Barria

  • June 5, 2026

  • 0 min

Share

Clinical Report: Antibody Functionality Profile Indicates Protective Mechanisms in Andes Hantavirus Survivors

Overview

This study investigates the role of antibody functionality in Andes hantavirus survivors, highlighting the significance of Fc-mediated effector functions in protective immunity.

Background

Andes orthohantavirus (ANDV) is a significant public health threat due to its high mortality rates and potential for human-to-human transmission. Understanding the immune response to ANDV is crucial for developing effective vaccines and therapeutics, especially as no specific antiviral treatments are currently available. The role of neutralizing antibodies and their Fc-mediated functions in survival from hantavirus cardiopulmonary syndrome (HCPS) remains an important area of research.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

  • Moderate disease in acute HCPS patients is associated with higher IgG levels against the Gn glycoprotein.
  • Fc-mediated effector functions, including antibody-dependent NK cell activation and ADCD, are stronger in patients with moderate disease compared to severe cases.
  • Survivors exhibit elevated IgG and IgM responses against Gn, with polyfunctional non-neutralizing IgG activities persisting for years.
  • Responses are more pronounced against the GnGc complex than against Gn alone.
  • Fc effector functions are identified as important correlates of protection against ANDV.

Clinical Implications

The findings suggest that monitoring antibody functionality, particularly Fc-mediated effector functions, may provide insights into patient outcomes in ANDV infections. This knowledge could inform the development of future vaccines and therapeutic strategies targeting hantaviruses.

Conclusion

The study underscores the complexity of the humoral immune response to ANDV and its implications for protective immunity. Understanding these mechanisms is vital for advancing vaccine development against hantavirus infections.

Related Resources & Content

  1. Open Forum Infectious Diseases, 2026 -- Dynamics of Anti-Nonstructural Protein 1 Antibodies and Their Correlation with Disease Severity in Children with Dengue
  2. The Journal of Infectious Diseases, 2026 -- Correlation Between Anti-Dengue Virus Antibody Avidity and Protection Against Symptomatic Dengue Infections
  3. The Journal of Infectious Diseases, 2026 -- Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines
  4. The Journal of Infectious Diseases, 2026 -- Antibody Levels From High-Throughput Variant-Specific SARS-CoV-2 Anti-Spike Immunoglobulin G and Angiotensin-Converting Enzyme 2 Neutralization Assays Correlate With COVID-19 Infection Risk in a Large Population
  5. Hantavirus, WHO, 2026 -- Hantavirus
  6. Clinician Brief: Hantavirus Pulmonary Syndrome (HPS) | Hantavirus | CDC, 2026 -- Clinical Overview
  7. Frontiers, 2026 -- Polyfunctional antibody signature define protection in Andes hantavirus survival
  8. Hantavirus
  9. Clinician Brief: Hantavirus Pulmonary Syndrome (HPS) | Hantavirus | CDC
  10. Frontiers | Polyfunctional antibody signature define protection in Andes hantavirus survival

Original Source(s)

Related Content